Status
Conditions
Treatments
About
Acute abdomen is a frequently encountered clinical condition that can be fatal if not diagnosed early. Acute appendicitis is one of the causes of acute abdomen and is the most common clinical condition leading to acute abdomen worldwide. Therefore, early diagnosis is crucial. Delays in diagnosis can lead to the complication of appendicitis and an increase in its complications, further worsening the clinical picture and raising morbidity and mortality rates.
In patients diagnosed with acute appendicitis, distinguishing between complicated and uncomplicated appendicitis is vital for treatment planning. The evaluation of patients' laboratory and radiological findings are widely used methods in clinical practice for this differentiation.
Recent studies have shown the HALP score has become a new prognostic biomarker in the literature, used to predict a range of clinical outcomes in various neoplasms. To date, the HALP score has been used to evaluate outcomes and prognosis in gastric, colorectal, bladder, prostate, and other cancers, as well as in many other diseases.
The purpose of this study is to determine the clinical impact of using the preoperatively calculated HALP score, derived from blood parameters, in the diagnosis, detection, and treatment of complicated acute appendicitis cases in the preoperative period without the need for additional diagnostic methods.
Full description
*Aim of the Study Acute abdomen is a frequently encountered clinical condition that can be fatal if not diagnosed early. Numerous diseases can cause acute abdomen, making accurate and rapid diagnosis extremely important. Acute appendicitis is one of the causes of acute abdomen and is the most common clinical condition leading to acute abdomen worldwide.
In a study by Addiss et al., the incidence of acute appendicitis was approximately 233 per 100,000 people. Although slightly more common in males, there is a lifetime risk of about 7%.
Therefore, early diagnosis is crucial. Delays in diagnosis can lead to the complication of appendicitis and an increase in its complications, further worsening the clinical picture and raising morbidity and mortality rates.
The reported incidence of complicated appendicitis and its complications in various studies ranges from approximately 20% to 30%. This significant rate increases the risk of morbidity and mortality. Thus, early diagnosis and treatment of appendicitis are of great importance to prevent the development of complications.
In patients diagnosed with acute appendicitis, distinguishing between complicated and uncomplicated appendicitis is vital for treatment planning. The evaluation of patients' laboratory and radiological findings are widely used methods in clinical practice for this differentiation.
Alongside laboratory and radiological findings, commonly used scoring systems are also available. Among these, the Alvarado scoring system, first described in 1986, is the most frequently used and popular system, and it remains the primary system consulted in patients with a preliminary diagnosis of acute appendicitis.
Beyond the Alvarado score, the Appendicitis Inflammatory Response (AIR) score, a more recently developed system, is also gaining widespread use. Furthermore, scoring systems created using artificial intelligence with current technologies have also been described.
In recent years, a new scoring system, the HALP score, was first developed by Chen et al. to predict the prognosis of gastric carcinomas. This score is calculated as [hemoglobin (g/L) × albumin (g/L) × lymphocytes (/L)] / platelets (/L).
Recent studies have shown the HALP score has become a new prognostic biomarker in the literature, used to predict a range of clinical outcomes in various neoplasms. Its use has become widespread because HALP is a scoring system composed of routinely used parameters, such as platelet and lymphocyte counts, albumin (indicating nutritional status), and hemoglobin (indicating anemic status).
To date, the HALP score has been used to evaluate outcomes and prognosis in gastric, colorectal, bladder, prostate, and other cancers, as well as in many other diseases.
The purpose of this study is to determine the clinical impact of using the preoperatively calculated HALP score, derived from blood parameters, in the diagnosis, detection, and treatment of complicated acute appendicitis cases in the preoperative period without the need for additional diagnostic methods.
For comparing categorical data, the Chi-square analysis or Fisher's exact test will be used. Categorical data will be presented as count (n) and percentage (%). Univariate analysis will be performed to identify factors effective in the preoperative prediction of complicated acute appendicitis, followed by multivariate analysis. A probability value of P<0.05 will be considered statistically significant.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
411 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal